Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Catalyx is building the complete back-end infrastructure for space: hardware, software, and operations that make upmass and ...

The result marks a potential advance for dual-targeting antibody drugs like Tecvayli, which are currently relegated to later-line settings for the persistent blood cancer. Tecvayli is one of many ...

Abstract: To meet ever-increasing load demand and to re-duce carbon footprints, integration of renewable-based power generation in the form of distributed generation (DGs) gives birth to the concept ...

Zenas BioPharma secures a $2B licensing deal with InnoCare, expanding its pipeline with orelabrutinib for global non-oncology indications. ZBIO's two late-stage candidates, obexelimab and ...

This year has brought a range of challenges for biopharma companies and their leaders, including on-and-off tariff threats and President Donald Trump's arm-twisting around overseas drug spending. Now, ...